CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Valganciclovirdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00374686
NCT00374686N/ACompleted
CompareCT.gov

Prophylactic Vs Preemptive Oral Valganciclovir for Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients: A Clinical and Pharmacoeconomic Study

Washington University School of Medicine·interventional·Posted Sep 11, 2006·Updated Sep 11, 2006

In Brief

A clinical study evaluating Valganciclovir for Cytomegalovirus Infection. Completed, across 1 site.

Detailed Summary

This is a study of prophylactic Vs preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients looking at clinical and pharmacoeconomic outcomes

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCytomegalovirus Infection
CountriesUnited States
CollaboratorsHoffmann-La Roche

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 11, 2006
Enrollment StartMar 1, 2003
Study CompletionSep 1, 2005
TodayJul 2, 2026
Posted 19.8 years ago

Interventions

Valganciclovirdrug